Please note: In order to keep Hive up to date and provide users with the best features, we are no longer able to fully support Internet Explorer. The site is still available to you, however some sections of the site may appear broken. We would encourage you to move to a more modern browser like Firefox, Edge or Chrome in order to experience the site fully.

A National Cancer Clinical Trials System for the 21st Century : Reinvigorating the NCI Cooperative Group Program, Paperback / softback Book

A National Cancer Clinical Trials System for the 21st Century : Reinvigorating the NCI Cooperative Group Program Paperback / softback

Edited by John Mendelsohn, Harold L. Moses, Sharyl J. Nass

Paperback / softback

Description

The National Cancer Institute's (NCI) Clinical Trials Cooperative Group Program has played a key role in developing new and improved cancer therapies.

However, the program is falling short of its potential, and the IOM recommends changes that aim to transform the Cooperative Group Program into a dynamic system that efficiently responds to emerging scientific knowledge; involves broad cooperation of stakeholders; and leverages evolving technologies to provide high-quality, practice-changing research. Table of ContentsFront MatterExecutive SummaryOverview of Conclusions and Recommendations1 Introduction2 The Science of Developing Cancer Therapy3 Operations, Oversight, and Funding of Cancer Clinical Trials4 Physician and Patient Participation in Cancer Clinical TrialsAppendix A: Previous and Ongoing Analyses Undertaken by NCIAppendix B: Committee Member and Staff BiographiesAcronymsGlossary

Information

Other Formats

Save 5%

£71.00

£66.95

 
Free Home Delivery

on all orders

 
Pick up orders

from local bookshops

Information